⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pipecolic Acid SCHEMBL22016 | 1.00 | — | — | |
| Pipecolic Acid SCHEMBL1002076 | 1.00 | BLM (0.45) | — | |
| Pipecolic Acid SCHEMBL40185 | 1.00 | — | — | |
| Pipecolic Acid SCHEMBL4758702 | 1.00 | BLM (0.45) | — | |
| Pipecolic Acid SCHEMBL1078450 | 1.00 | BLM (0.45) | — | |
| Pipecolic Acid SCHEMBL30552181 | 1.00 | — | — | |
| Pipecolic Acid SCHEMBL29479229 | 1.00 | — | — | |
| SCHEMBL23997628 | 0.98 | MEN1 (0.43) | — | |
| SCHEMBL6235834 | 0.98 | MEN1 (0.43) | — | |
| SCHEMBL5568760 | 0.98 | MEN1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 860 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745152-A2 | PEPTIDES BINDING TO BFL-1 | Dana-Farber Cancer Institute, Inc. (US) | 2026-05-20 | — | — | EP | claimed |
| CN-122010885-A | Oraglycone intermediate, preparation method thereof and method for preparing key intermediate of Oraglycone | 江西同和药业股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122005617-A | Application of active ruminococcus in preparing medicament for preventing or treating children obesity related cognitive dysfunction | 华中科技大学 | 2026-05-12 | — | — | CN | claimed |
| EP-3341008-B1 | PEPTIDES BINDING TO BFL-1 | DANA FARBER CANCER INST INC (US) | 2026-04-15 | — | — | EP | claimed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| US-20250129125-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2025-04-24 | — | — | US | claimed |
| EP-4541891-A1 | NOVEL LRP1-BINDING PEPTIDE | Ichimaru Pharcos Co., Ltd. (JP) | 2025-04-23 | — | — | EP | claimed |
| CN-119447390-B | Cross-linked polybenzimidazole anion exchange membrane and preparation method thereof | 东华大学 | 2025-04-01 | — | — | CN | claimed |
| CN-119447390-A | Cross-linked polybenzimidazole anion exchange membrane and preparation method thereof | 东华大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2025032025-A1 | STABLE GLASSY MATERIAL BASED ON HISTIDINE, ARGININE AND GLUTAMIC ACID AMINO ACIDS | VITROPEP (FR) | 2025-02-13 | — | — | WO | claimed |
| EP-2068878-A2 | RHO KINASE INHIBITORS | Boehringer Ingelheim International GmbH (DE) | 2009-06-17 | — | — | EP | claimed |
| EP-1585749-B1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER (US) | 2008-08-13 | — | — | EP | claimed |
| US-20080161297-A1 | e.g. N-(7-Chloro-1-oxo-1,2-dihydro-isoquinolin-6-yl)-2-dimethylamino-2-phenyl-acetamide; hypertension, atherosclerosis, restenosis, stroke, heart failure, coronary vasospasm, cerebral vasospasm, ischemia/reperfusion injury, pulmonary hypertension, angina, myocardial infarction, | ALCON INC. (CH) | 2008-07-03 | — | — | US | claimed |
| WO-2008036540-A2 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-03-27 | — | — | WO | claimed |
| WO-2006071079-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2006-07-06 | — | — | WO | claimed |
| CN-1759118-A | Diazepinoindole derivatives as kinase inhibitors | PFIZER (US) | 2006-04-12 | — | — | CN | claimed |
| EP-1585749-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2005-10-19 | — | — | EP | claimed |
| WO-2004063198-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2004-07-29 | — | — | WO | claimed |
| EP-0614986-B1 | Enzymatic racemate cleavage of 2-pipéridine alkylcarboxylates | SYNTHELABO (FR) | 1999-07-21 | — | — | EP | claimed |
| EP-0614986-A1 | Enzymatic racemate cleavage of 2-pipéridine alkylcarboxylates and their use as synthesis intermediates | SYNTHELABO (FR) | 1994-09-14 | — | — | EP | claimed |